遇见数据集

Tumor characteristics for groups of patients for whom optimal OAR sparing and tumor volume dose coverage can be achieved with HT or any one form of VMAT (Group 1) and those patients among whom optimal OAR sparing cannot be achieved if optimal tumor volume coverage is desired with VMAT (Group 2).

收藏
NIAID Data Ecosystem2026-03-07 收录
官方服务:

资源简介:

Tumor characteristics for groups of patients for whom optimal OAR sparing and tumor volume dose coverage can be achieved with HT or any one form of VMAT (Group 1) and those patients among whom optimal OAR sparing cannot be achieved if optimal tumor volume coverage is desired with VMAT (Group 2).

创建时间:
2013-04-05
二维码
社区交流群
二维码
科研交流群
商业服务